BIOREGENX, INC. (BRGX)
↓ Download CSV- Sector Services
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, BIOREGENX, INC. reported revenue of $1.85M, down 20.8% from the prior year. The company ran a net loss, with a net margin of -83.2% and a gross margin of 81.1%. It held $411.0K in total assets against $4.95M in total liabilities.
Key ratios (FY2025)
81.1%
Gross margin
-67.1%
Operating margin
-83.2%
Net margin
-20.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.85M | $2.34M | $3.41M | $42.2K | $198.6K | — |
| Cost of Revenue | $350.9K | $681.7K | $1.10M | $0 | $554 | — |
| Gross Profit | $1.50M | $1.66M | $2.31M | $42.2K | $198.0K | — |
| Operating Income | -$1.24M | -$22.76M | -$3.41M | -$78.3K | -$165.1K | — |
| Net Income | -$1.54M | -$23.05M | -$3.60M | -$78.3K | -$96.9K | — |
| EPS (Diluted) | $0.00 | $-0.03 | $-0.01 | $0.00 | $0.00 | — |
| Total Assets | $411.0K | $508.5K | $865.8K | $59.1K | $127.8K | — |
| Total Liabilities | $4.95M | $3.89M | $2.94M | $260.7K | $212.0K | — |
| Shareholders' Equity | -$4.54M | -$3.38M | -$2.07M | -$2.53M | -$84.2K | $177.6K |
| Cash & Equivalents | — | $58.4K | $125.4K | — | — | — |
| Operating Cash Flow | $39.0K | -$324.1K | -$1.52M | -$64.7K | -$119.5K | — |
| Capital Expenditures | $9.1K | $189.4K | $0 | — | — | — |
| Shares Outstanding | 959.71M | 912.37M | 639.78M | 269.75M | 269.75M | — |